These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Tenecteplase versus alteplase for acute ischemic stroke. González RG N Engl J Med; 2012 Jul; 367(3):275-6; author reply 276. PubMed ID: 22808969 [No Abstract] [Full Text] [Related]
8. Novel lytics, novel imaging: a new treatment strategy in stroke? Quinn TJ; Dawson J J Comp Eff Res; 2012 Jul; 1(4):311-4. PubMed ID: 24237464 [TBL] [Abstract][Full Text] [Related]
9. Alteplase for stroke. Patients and doctors are being misled by promotional pressures. Li J; Nathanson LA; Mills TJ; Netland KE; Paula R; Ragland D BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092605 [No Abstract] [Full Text] [Related]
10. Alteplase for stroke. Why were these authors of the commentaries chosen? Hoffman JR BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092608 [No Abstract] [Full Text] [Related]
11. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type of the Canadian alteplase for stroke effectiveness study registry. Libman R; Kwiatkowski T Stroke; 2007 Sep; 38(9):e88. PubMed ID: 17673802 [No Abstract] [Full Text] [Related]
12. Alteplase for stroke. Financial information is needed to ensure objectivity. Solomon RC BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092607 [No Abstract] [Full Text] [Related]
13. Questions about authorisation of alteplase for ischaemic stroke. Shinton R Lancet; 2014 Aug; 384(9944):659-60. PubMed ID: 25152265 [No Abstract] [Full Text] [Related]
14. Stroke guideline supports expanded alteplase use. Traynor K Am J Health Syst Pharm; 2013 Mar; 70(6):474, 476, 478. PubMed ID: 23456396 [No Abstract] [Full Text] [Related]
15. Alteplase for ischaemic stroke--much sooner is much better. Saver JL; Levine SR Lancet; 2010 May; 375(9727):1667-8. PubMed ID: 20472152 [No Abstract] [Full Text] [Related]
16. Alteplase for acute stroke revisited: the first 10 years. Lyden PD; Lees KR; Davis SM Lancet Neurol; 2006 Sep; 5(9):722-4. PubMed ID: 16914399 [No Abstract] [Full Text] [Related]
17. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study]. Di Pasquale G Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744 [No Abstract] [Full Text] [Related]
18. A panoramic, practice-based view of intravenous alteplase 3-4.5 h after stroke. Kasner SE; Levine SR Lancet Neurol; 2010 Sep; 9(9):843-5. PubMed ID: 20667791 [No Abstract] [Full Text] [Related]
19. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study. Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M; J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972 [TBL] [Abstract][Full Text] [Related]
20. Implementation of thrombolysis for ischaemic stroke. Dirks M; Dippel DW Lancet Neurol; 2013 Feb; 12(2):120-1. PubMed ID: 23260190 [No Abstract] [Full Text] [Related] [Next] [New Search]